ARQIS advises BWK on the acquisition of a majority stake in H & R Industrierohbau

27. June 2018

ARQIS has advised BWK GmbH Unternehmensbeteiligungsgesellschaft (BWK) on the acquisition of a majority stake in H & R Industrierohrbau GmbH.

H & R Industrierohrbau GmbH, based in Goldbach in Bavaria, is specialized in the maintenance and construction of piping in production facilities. In 2017, the company generated a turnover of almost 16 million Euros with 80 employees at its three locations – two of which are “on-site locations” at industrial parks in the Rhine-Main area. Among H & R’s customer base are major companies of the chemical and pharmaceutical sectors (e.g. AkzoNobel, Boehringer Ingelheim, Sanofi, and Clariant) as well as other medium-sized industrial customers.

“H & R is exceptionally well positioned on the market and has an outstanding reputation. We are confident that we can support H & R’s growth constructively,” states Dr. Bernd Bergschneider of BWK’s executive board. Rainer Miller, a member of BWK’ management says: “Together with H & R, we will establish additional locations and eventually be present in further industrial parks via ‘Buy & Build’”.

BWK GmbH Unternehmensbeteiligungsgesellschaft, based in Stuttgart, is one of the longest established German capital investment companies and pursues a long-term investment approach.This spring, ARQIS has already advised BWK GmbH on the acquisition of a minority stake in CruiseVision GmbH, one of the leading technology providers of photo and video products on ocean-going cruise ships.

Advisors to BWK GmbH

ARQIS Rechtsanwälte (Dusseldorf): Dr. Christof Alexander Schneider (lead; Corporate/M&A), Dr. Andrea Panzer-Heemeier (labour law), Dr. Ulrich Lienhard (real estate), Dimitrios Christopoulos (commercial), Marcus Nothhelfer (IP; Munich); Associates: Nima Hanifi-Atashgah (Corporate/M&A), Jennifer Huschauer (real estate), Waldemar Rembold (commercial), Dr. Markus Schwipper (labour law), Dr. Philipp Maier (IP; both Munich)


If you have any questions, please write to us.